BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 21546410)

  • 1. Activation of the signal transducer and activator of transcription 3 pathway up-regulates estrogen receptor-beta expression in lung adenocarcinoma cells.
    Wang HC; Yeh HH; Huang WL; Lin CC; Su WP; Chen HH; Lai WW; Su WC
    Mol Endocrinol; 2011 Jul; 25(7):1145-58. PubMed ID: 21546410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression.
    Lo HW; Hsu SC; Xia W; Cao X; Shih JY; Wei Y; Abbruzzese JL; Hortobagyi GN; Hung MC
    Cancer Res; 2007 Oct; 67(19):9066-76. PubMed ID: 17909010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 induces proliferation in adult spinal cord-derived neural progenitors via the JAK2/STAT3 pathway with EGF-induced MAPK phosphorylation.
    Kang MK; Kang SK
    Cell Prolif; 2008 Jun; 41(3):377-92. PubMed ID: 18485152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells.
    Huang WL; Yeh HH; Lin CC; Lai WW; Chang JY; Chang WT; Su WC
    Mol Cancer; 2010 Dec; 9():309. PubMed ID: 21122157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription-3 with epidermal growth factor receptor blockade in lung cancer.
    Kluge A; Dabir S; Kern J; Nethery D; Halmos B; Ma P; Dowlati A
    Int J Cancer; 2009 Oct; 125(7):1728-34. PubMed ID: 19569236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
    Pozios I; Seel NN; Hering NA; Hartmann L; Liu V; Camaj P; Müller MH; Lee LD; Bruns CJ; Kreis ME; Seeliger H
    Cell Oncol (Dordr); 2021 Feb; 44(1):167-177. PubMed ID: 32940862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p14(ARF) inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway.
    Ozenne P; Dayde D; Brambilla E; Eymin B; Gazzeri S
    Oncogene; 2013 Feb; 32(8):1050-8. PubMed ID: 22450744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
    Lee TL; Yeh J; Van Waes C; Chen Z
    Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas.
    Gao SP; Mark KG; Leslie K; Pao W; Motoi N; Gerald WL; Travis WD; Bornmann W; Veach D; Clarkson B; Bromberg JF
    J Clin Invest; 2007 Dec; 117(12):3846-56. PubMed ID: 18060032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor β exerts tumor repressive functions in human malignant pleural mesothelioma via EGFR inactivation and affects response to gefitinib.
    Pinton G; Thomas W; Bellini P; Manente AG; Favoni RE; Harvey BJ; Mutti L; Moro L
    PLoS One; 2010 Nov; 5(11):e14110. PubMed ID: 21124760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in claudin-2 expression by an EGFR/MEK/ERK/c-Fos pathway in lung adenocarcinoma A549 cells.
    Ikari A; Sato T; Watanabe R; Yamazaki Y; Sugatani J
    Biochim Biophys Acta; 2012 Jun; 1823(6):1110-8. PubMed ID: 22546605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen Receptor β Is Involved in Acquired Resistance to EGFR-tyrosine Kinase Inhibitors in Lung Cancer.
    Sugiura H; Miki Y; Iwabuchi E; Saito R; Ono K; Sato I; Okada Y; Sasano H
    Anticancer Res; 2021 May; 41(5):2371-2381. PubMed ID: 33952462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor upregulates endometrial CYR61 expression via activation of the JAK2/STAT3 pathway.
    Klein R; Stiller S; Gashaw I
    Reprod Fertil Dev; 2012; 24(3):482-9. PubMed ID: 22401280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERβ-mediated estradiol enhances epithelial mesenchymal transition of lung adenocarcinoma through increasing transcription of midkine.
    Zhao G; Nie Y; Lv M; He L; Wang T; Hou Y
    Mol Endocrinol; 2012 Aug; 26(8):1304-15. PubMed ID: 22669742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer.
    Samanta S; Sharma VM; Khan A; Mercurio AM
    Oncogene; 2012 Nov; 31(44):4689-97. PubMed ID: 22266872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas.
    Colomiere M; Ward AC; Riley C; Trenerry MK; Cameron-Smith D; Findlay J; Ackland L; Ahmed N
    Br J Cancer; 2009 Jan; 100(1):134-44. PubMed ID: 19088723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC.
    Chaib I; Karachaliou N; Pilotto S; Codony Servat J; Cai X; Li X; Drozdowskyj A; Servat CC; Yang J; Hu C; Cardona AF; Vivanco GL; Vergnenegre A; Sanchez JM; Provencio M; de Marinis F; Passaro A; Carcereny E; Reguart N; Campelo CG; Teixido C; Sperduti I; Rodriguez S; Lazzari C; Verlicchi A; de Aguirre I; Queralt C; Wei J; Estrada R; Puig de la Bellacasa R; Ramirez JL; Jacobson K; Ditzel HJ; Santarpia M; Viteri S; Molina MA; Zhou C; Cao P; Ma PC; Bivona TG; Rosell R
    J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28376152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling.
    Song L; Rawal B; Nemeth JA; Haura EB
    Mol Cancer Ther; 2011 Mar; 10(3):481-94. PubMed ID: 21216930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGF promotes HIF-1α expression in colorectal cancer cells and tumor metastasis by regulating phosphorylation of STAT3.
    Zhao FL; Qin CF
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1055-1062. PubMed ID: 30779072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 regulates MMP-10 expression via JAK2/STAT3 signaling pathway in a human lung adenocarcinoma cell line.
    Zhang X; Yin P; DI D; Luo G; Zheng L; Wei J; Zhang J; Shi Y; Zhang J; Xu N
    Anticancer Res; 2009 Nov; 29(11):4497-501. PubMed ID: 20032397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.